Sino Biological Inc
SZSE:301047
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
54.7
89.5
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one Sino Biological Inc stock under the Base Case scenario is 57.22 CNY. Compared to the current market price of 65.6 CNY, Sino Biological Inc is Overvalued by 13%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Sino Biological Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for Sino Biological Inc cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Sino Biological Inc
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Sino Biological Inc
Balance Sheet Decomposition
Sino Biological Inc
Current Assets | 4.5B |
Cash & Short-Term Investments | 4.2B |
Receivables | 166.2m |
Other Current Assets | 98.7m |
Non-Current Assets | 1.8B |
Long-Term Investments | 436.5m |
PP&E | 909.4m |
Intangibles | 337.3m |
Other Non-Current Assets | 160.7m |
Current Liabilities | 174.3m |
Accounts Payable | 17.2m |
Accrued Liabilities | 41.9m |
Other Current Liabilities | 115.2m |
Non-Current Liabilities | 97.5m |
Long-Term Debt | 48.9m |
Other Non-Current Liabilities | 48.6m |
Earnings Waterfall
Sino Biological Inc
Revenue
|
659.7m
CNY
|
Cost of Revenue
|
-147.5m
CNY
|
Gross Profit
|
512.1m
CNY
|
Operating Expenses
|
-398.5m
CNY
|
Operating Income
|
113.6m
CNY
|
Other Expenses
|
81.8m
CNY
|
Net Income
|
195.4m
CNY
|
Free Cash Flow Analysis
Sino Biological Inc
CNY | |
Free Cash Flow | CNY |
Profitability Score
Profitability Due Diligence
Sino Biological Inc's profitability score is 54/100. The higher the profitability score, the more profitable the company is.
Score
Sino Biological Inc's profitability score is 54/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Sino Biological Inc's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
Sino Biological Inc's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Sino Biological Inc
According to Wall Street analysts, the average 1-year price target for Sino Biological Inc is 104.04 CNY with a low forecast of 103.02 CNY and a high forecast of 107.1 CNY.
Dividends
Current shareholder yield for Sino Biological Inc is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Sino Biological Inc. provides protein, antibody and gene products. The company is headquartered in Beijing, Beijing and currently employs 495 full-time employees. The company went IPO on 2021-08-16. The firm's main business includes products such as recombinant proteins, antibodies, genes and culture media, as well as the development of recombinant proteins and antibodies, and biological analysis and testing services. The firm operates in the domestic market and overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one Sino Biological Inc stock under the Base Case scenario is 57.22 CNY.
Compared to the current market price of 65.6 CNY, Sino Biological Inc is Overvalued by 13%.